For S100A7, the lower transcript levels observed in the cancer cell lines than in the control cell line are in agreement with the study of Liu et al., who reported lower levels of S100A7 in a cohort of 45 pancreatic ductal adenocarcinomas when compared to adjacent non-tumor tissues [21]. Here, S100A7 is linked to pancreatic ductal adenocarcinoma.